8-KRegulation FDOther EventsExhibits & Filings

EIDP, Inc. 8-K Report, Regulation FD Disclosure (Dec 18, 2014)

Filed December 18, 2014For Securities:CTA-PBCTA-PA

Summary

E. I. du Pont de Nemours and Company (DuPont) filed an 8-K on December 18, 2014, providing updates on its plan to separate its Performance Chemicals segment. The filing includes a presentation for investor interactions and announces key developments regarding the spin-off. This action is part of DuPont's broader strategy to streamline operations and enhance shareholder value by focusing on core businesses. The significant development is the official naming of the new, independent Performance Chemicals company as The Chemours Company. The company also revealed Chemours' leadership team, signaling progress towards the planned separation. Investors should note that the information furnished in this 8-K is for informational purposes and not deemed 'filed' for liability purposes, but it provides crucial insight into the execution of DuPont's strategic divestiture.

Key Highlights

  • 1DuPont is proceeding with its plan to separate its Performance Chemicals segment.
  • 2The new, independent Performance Chemicals company will be named The Chemours Company.
  • 3The leadership team for The Chemours Company has been announced.
  • 4A presentation regarding the Form 10 and related matters for the separation is being furnished to investors.
  • 5DuPont filed a registration statement on Form 10 with the SEC for the separation.
  • 6The company also provided an update on its redesign initiative.
  • 7Information is furnished under Regulation FD Disclosure and is not deemed 'filed' for Section 18 liability.

Frequently Asked Questions

The main purpose of this filing is to provide investors with updates on DuPont's plan to separate its Performance Chemicals segment, including the official naming of the new company and its leadership.

The new, independent Performance Chemicals company will be named The Chemours Company.

The presentation is for investor interactions and covers matters related to the Form 10 filing and the separation of the Performance Chemicals segment.

The information furnished under Item 7.01, including Exhibit 99.1, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, meaning it is not subject to the liability provisions of that section.